Bird Flu Vaccine Development: Gain-of-Function Concerns and Government Funding

Government Funding for Bird Flu Vaccine

• 💰 The Biden administration awarded $590 million in taxpayer dollars to Madna for the development of a bird flu vaccine.
• ⚠️ This contract was previously cancelled by the Trump administration.

Concerns Over Gain-of-Function Research

• 🔬 Bird flu is currently not transmissible from human to human, but the potential for this is linked to gain-of-function manipulation.
• 💡 Dr. Kelly Victory stated that developing a bird flu vaccine is dangerous and potentially not worth the risk due to lab errors or nefarious intent.
• ⚠️ Over a hundred serious lab errors or leaks are reported annually, highlighting the risks of manipulating viruses.

Alternative Treatments and Vaccine Necessity

• 💊 Dr. Victory noted that bird flu can be treated with therapeutics like hydroxychloroquine and chloroquine.
• ❓ The necessity of a vaccine for a virus that may be manipulated in a lab is questioned, drawing an analogy to shampoo creating a problem that conditioner solves.

Private Sector Involvement and Risks

• 🚫 Trump's executive order against gain-of-function research only applies to government-funded research.
• 🧐 A private company, potentially with vested interests, could still proceed with bird flu vaccine development, raising concerns about unchecked research.
• 📊 While taxpayer dollars may not fund a bird flu vaccine, the possibility of private entities pursuing it remains a concern.